» Authors » Sith Sathornsumetee

Sith Sathornsumetee

Explore the profile of Sith Sathornsumetee including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 57
Citations 3940
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodponthukwaji K, Khowawisetsut L, Limjunyawong N, Kunwong N, Duangchan K, Sripinitchai S, et al.
J Biomed Mater Res A . 2025 Feb; 113(3):e37886. PMID: 39972623
Although the mono-anticancer therapy approach particularly directly targeting tumors is still common, this conventional method is generally deemed not effective and insufficient. In tumor microenvironment (TME), tumor-associated macrophages (TAMs, referred...
2.
Thongrattana W, Arigul T, Suktitipat B, Pithukpakorn M, Sathornsumetee S, Wongsurawat T, et al.
Bioinform Adv . 2024 May; 4(1):vbae058. PMID: 38736685
Summary: The revised WHO guidelines for classifying and grading brain tumors include several copy number variation (CNV) markers. The turnaround time for detecting CNVs and alterations throughout the entire genome...
3.
Bovonsunthonchai S, Witthiwej T, Vachalathiti R, Hengsomboon P, Thong-On S, Sathornsumetee S, et al.
Sci Rep . 2024 Jan; 14(1):2053. PMID: 38267518
Idiopathic Normal Pressure Hydrocephalus (iNPH) is a neurological condition that often presents gait disturbance in the early stages of the disease and affects other motor activities. This study investigated changes...
4.
Wongsurawat T, Jenjaroenpun P, Anekwiang P, Arigul T, Thongrattana W, Jamshidi-Parsian A, et al.
Brain Pathol . 2023 Aug; 34(1):e13203. PMID: 37574201
The 2021 WHO Classification of Central Nervous System Tumors recommended evaluation of cyclin-dependent kinase inhibitor 2A/B (CDKN2A/B) deletion in addition to codeletion of 1p/19q to characterize IDH-mutant gliomas. Here, we...
5.
Dana P, Pimpha N, Chaipuang A, Thumrongsiri N, Tanyapanyachon P, Taweechaipaisankul A, et al.
Nanomaterials (Basel) . 2022 Aug; 12(15). PMID: 35957037
Selenium nanoparticles (SeNPs) were synthesized to overcome the limitations of selenium, such as its narrow safe range and low water solubility. SeNPs reduce the toxicity and improve the bioavailability of...
6.
Srinoulprasert Y, Kumkamthornkul P, Tuchinda P, Wongwiangjunt S, Sathornsumetee S, Jongjaroenprasert K, et al.
Cytokine . 2022 Jun; 157:155951. PMID: 35772364
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug reactions with eosinophilia and systemic symptoms (DRESS) are the most common severe cutaneous adverse drug reactions (SCARs). Anti-epileptic drugs are one of the...
7.
Thumrongsiri N, Dana P, Bawab R, Tanyapanyachon P, Treetidnipa C, Saengkrit N, et al.
Biomed Pharmacother . 2022 Apr; 150:112979. PMID: 35461090
Primary central nervous system lymphoma (PCNSL) is a form of extranodal non-Hodgkin's B-cell lymphoma limited to the CNS. The treatment of PCNSL is ineffective partly due to the blood-brain barrier...
8.
Suwala A, Felix M, Friedel D, Stichel D, Schrimpf D, Hinz F, et al.
Acta Neuropathol . 2021 Dec; 143(2):263-281. PMID: 34967922
Oligodendrogliomas are defined at the molecular level by the presence of an IDH mutation and codeletion of chromosomal arms 1p and 19q. In the past, case reports and small studies...
9.
Sathornsumetee S, Nunta-Aree S, Cheunsuchon P
Neurooncol Adv . 2021 Aug; 3(1):vdab093. PMID: 34345822
No abstract available.
10.
Santisukwongchote S, Teerapakpinyo C, Chankate P, Techavichit P, Boongird A, Sathornsumetee S, et al.
Pathol Res Pract . 2021 May; 223:153483. PMID: 34022681
The most recent WHO classification (2016) for gliomas introduced integrated diagnoses requiring both phenotypic and genotypic data. This approach presents difficulties for countries with limited resources for laboratory testing. The...